ANRO
Alto Neuroscience Inc.

1,103
Mkt Cap
$443.63M
Volume
137,277.00
52W High
$16.49
52W Low
$1.60
PE Ratio
-6.21
ANRO Fundamentals
Price
$14.55
Prev Close
$14.28
Open
$14.06
50D MA
$11.04
Beta
1.74
Avg. Volume
412,500.95
EPS (Annual)
-$2.50
P/B
3.48
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of "Moderate Buy" from Analysts
Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight ratings firms that are covering the company, MarketBeat reports. One...
MarketBeat·14d ago
News Placeholder
More News
News Placeholder
What is Chardan Capital's Forecast for ANRO FY2025 Earnings?
Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Equities researchers at Chardan Capital issued their FY2025 EPS estimates for Alto Neuroscience in a research note issued to investors on...
MarketBeat·18d ago
News Placeholder
Alto Neuroscience (NYSE:ANRO) Upgraded at Chardan Capital
Chardan Capital upgraded shares of Alto Neuroscience to a "strong-buy" rating in a report on Wednesday...
MarketBeat·19d ago
News Placeholder
Alto Neuroscience (NYSE:ANRO) Hits New 12-Month High - Time to Buy?
Alto Neuroscience (NYSE:ANRO) Hits New 52-Week High - What's Next...
MarketBeat·20d ago
News Placeholder
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
read more...
Benzinga·24d ago
News Placeholder
Alto Neuroscience (NYSE:ANRO) Upgraded at Wall Street Zen
Wall Street Zen upgraded Alto Neuroscience from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·26d ago
News Placeholder
Is Alto Neuroscience, Inc. (ANRO) Outperforming Other Medical Stocks This Year?
Here is how Alto Neuroscience, Inc. (ANRO) and Editas Medicine (EDIT) have performed compared to their sector so far this year.
Zacks·27d ago
News Placeholder
Robert W. Baird Issues Positive Forecast for Alto Neuroscience (NYSE:ANRO) Stock Price
Robert W. Baird raised their price objective on Alto Neuroscience from $16.00 to $22.00 and gave the company an "outperform" rating in a report on Thursday...
MarketBeat·27d ago
News Placeholder
Jefferies Financial Group Forecasts Strong Price Appreciation for Alto Neuroscience (NYSE:ANRO) Stock
Jefferies Financial Group upped their price target on Alto Neuroscience from $15.00 to $25.00 and gave the stock a "buy" rating in a research note on Wednesday...
MarketBeat·28d ago
News Placeholder
Alto Neuroscience (NYSE:ANRO) Issues Earnings Results
Alto Neuroscience (NYSE:ANRO - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.52) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·28d ago

Latest ANRO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.